Integrating artificial intelligence and bio-signals into early warning systems promises to overcome conventional limitations and improve the early detection of patient clinical deterioration.
Does integrating AI-based bio-signal monitoring into early warning systems improve the detection of clinical deterioration compared to conventional EWS?
Integrating AI and continuous bio-signal monitoring into early warning systems represents a promising approach to overcome the limitations of conventional EWS and improve the early detection of clinical deterioration.
Early warning score (EWS) have become an essential component of patient safety strategies in healthcare environments worldwide. These systems aim to identify patients at risk of clinical deterioration by evaluating vital signs and other physiological parameters, enabling timely intervention by rapid response teams. Despite proven benefits and widespread adoption, conventional EWS have limitations that may affect their ability to effectively detect and respond to patient deterioration. There is growing interest in integrating continuous multimodal monitoring technologies and advanced analytics, particularly artificial intelligence (AI) and machine learning (ML)-based approaches, to address these limitations and enhance EWS performance. This review provides a comprehensive overview of the current state and potential future directions of AI-based bio-signal monitoring in early warning system. It examines emerging trends and techniques in AI and ML for bio-signal analysis, exploring the possibilities and potential applications of various bio-signals such as electroencephalography, electrocardiography, electromyography in early warning system. However, significant challenges exist in developing and implementing AI-based bio-signal monitoring systems in early warning system, including data acquisition strategies, data quality and standardization, interpretability and explainability, validation and regulatory approval, integration into clinical workflows, and ethical and legal considerations. Addressing these challenges requires a multidisciplinary approach involving close collaboration between healthcare professionals, data scientists, engineers, and other stakeholders. Future research should focus on developing advanced data fusion techniques, personalized adaptive models, real-time and continuous monitoring, explainable and reliable AI, and regulatory and ethical frameworks. By addressing these challenges and opportunities, the integration of AI and bio-signals into early warning systems can enhance patient monitoring and clinical decision support, ultimately improving healthcare quality and safety. In conclusion, integrating AI and bio-signals into the early warning system represents a promising approach to improve patient care outcomes and support clinical decision-making. As research in this field continues to evolve, it is crucial to develop safe, effective, and ethically responsible solutions that can be seamlessly integrated into clinical practice, harnessing the power of innovative technology to enhance patient care and improve individual and population health and well-being.
Park et al. (Wed,) conducted a review in Patient deterioration. Artificial intelligence-based bio-signal monitoring vs. Conventional Early Warning Scores (EWS) was evaluated. Integrating artificial intelligence and bio-signals into early warning systems promises to overcome conventional limitations and improve the early detection of patient clinical deterioration.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: